Prosecution Insights
Last updated: May 29, 2026

Kinki University

6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (50%)
0
Easy (0%)
3
Unknown (50%)

Rejection Statute Mix

BucketCases
§103 only2 (33%)
§102 only1 (17%)
No statute on record3 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RAO, SAVITHA M 1 60.7% +29.5%
OLSON, ANDREA STEFFEL 1 62.2% -12.5%
FIGG, TRAVIS M 1 61.7% +16.7%
REDDIG, PETER J 1 58.0% +40.0%
MCCORMICK, CATHERINE LYNN 1 46.9% +21.8%
JONES-FOSTER, ERICA NICOLE 1 49.3% +45.3%

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18275293 BOLUS FORMING MATERIAL AND BOLUS USING SAME FIGG, TRAVIS M 87d overdue
17623738 CELL CULTURE SCAFFOLD, PRODUCTION METHOD THEREOF, SCAFFOLD PRODUCTION KIT, AND PRODUCTION METHOD OF CELL CULTURE PRODUCT MCCORMICK, CATHERINE LYNN 72d overdue
18282572 CANCER CELL GROWTH INHIBITING COMPOSITION AND PROCESSED FOOD RAO, SAVITHA M 66d overdue
17311574 COLLAGEN SOLID, METHOD FOR PRODUCING COLLAGEN SOLID, BIOMATERIAL, AND EX VIVO MATERIAL JONES-FOSTER, ERICA NICOLE 14d
18268434 PHARMACEUTICAL COMPOSITION FOR AMELIORATING MALIGNANT DISEASES REDDIG, PETER J 21d

Top Art Units

Art UnitApps
1691 1
1693 1
1783 1
1646 1
1638 1
1656 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18282572 CANCER CELL GROWTH INHIBITING COMPOSITION AND PROCESSED FOOD RAO, SAVITHA M 1691 Other Non-Final OA 66d overdue Pending Sep 18, 2023
18276114 PHARMACEUTICAL COMPOSITION FOR PREVENTING CYTOKINE STORM OLSON, ANDREA STEFFEL 1693 Other Non-Final OA 66d overdue Pending Aug 07, 2023
18275293 BOLUS FORMING MATERIAL AND BOLUS USING SAME FIGG, TRAVIS M 1783 §102 Final Rejection 87d overdue Pending Aug 01, 2023
18268434 PHARMACEUTICAL COMPOSITION FOR AMELIORATING MALIGNANT DISEASES REDDIG, PETER J 1646 Other Non-Final OA 21d Pending Jun 20, 2023
17623738 CELL CULTURE SCAFFOLD, PRODUCTION METHOD THEREOF, SCAFFOLD PRODUCTION KIT, AND PRODUCTION METHOD OF CELL CULTURE PRODUCT MCCORMICK, CATHERINE LYNN 1638 §103 Non-Final OA 72d overdue Pending Dec 29, 2021
17311574 COLLAGEN SOLID, METHOD FOR PRODUCING COLLAGEN SOLID, BIOMATERIAL, AND EX VIVO MATERIAL JONES-FOSTER, ERICA NICOLE 1656 §103 Final Rejection 14d Pending Jun 07, 2021

Managing Kinki University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month